Search clinical trials for: 12 mg/mL nicotine strength e-liquid

Total 101 results

Virginia Polytechnic Institute and State University

Completed

Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace

Tobacco Use

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Understanding Factors That Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine Receptors

Electronic Cigarette Use

United States
Cedars-Sinai Medical Center

Terminated

E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion

Coronary Artery Disease | Myocardial Perfusion

United States
Yale University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes

Nicotine | E-liquid Flavors

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Flavors on Nicotine Reinforcement in Smokers

Nicotine Dependence

United States
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)

Tobacco Use

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Terminated

Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers

Electronic Cigarettes

United States
University of California, San Francisco
National Institute on Drug Abuse (NIDA)

Withdrawn

Vaping High vs. Low Nicotine E-Liquid

Cardiovascular Risk Factor | Nicotine Dependence

United States
RAI Services Company

Not yet recruiting

CSD231005 Nicotine Pouch Biomarkers of Exposure

Smoking | Tobacco Use

United States
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA); University of Pennsylvania

Completed

Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors

Smoking

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers

Tobacco Dependence

United States
Universita degli Studi di Catania
Lega Italiana Anti Fumo; Arbi Group Srl

Completed

Smoking Cessation and Reduction With an Electronic Nicotine Delivery Device (ENDD)

Smoking Cessation | Nicotine Dependence

Italy
El Instituto Nacional de Neurologia y Neurocirugia...
Howard University

Completed

Pilot Trial of Transnasal Nicotine in Parkinson Disease

Parkinson Disease

Mexico
Rose Research Center, LLC
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)

Completed

Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use (DUAL)

Cigarette Smoking | Nicotine Addiction

United States
University of Auckland, New Zealand
Auckland District Health Board; Health New Zealand Ltd, Christchurch, New Zealand

Completed

The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation (ASCEND-II)

Smoking Cessation

New Zealand
Leonardo Clavijo
Amgen

Unknown

Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI) (Evol-CLI)

Critical Limb Ischemia

United States
Alternative Research Initiative
Foundation for a Smoke-Free World

Not yet recruiting

Electronic Cigarettes and Nicotine Pouches for Smoking Cessation

Role of Tobacco Harm Reduction in Smoking Cessation | Efficiency and Efficacy of E-cigarettes and Nicotine Pouches | Adverse Effect of E-cigarettes and Nicotine Pouches

Pakistan
Oyster Point Pharma, Inc.

Completed

Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Long Term Follow up Dry Eye Disease

United States
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Recruiting

Concentration Impact Nicotine Salt (CINS)

Smoking Cessation | Vaping

Switzerland
University of Washington
National Center for Complementary and Integrative Health (NCCIH)

Withdrawn

Effects of Echinacea in Children

Upper Respiratory Infections
Taiwan Liposome Company

Completed

Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients

Osteoarthritis of the Knee

Taiwan, Australia
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions

Healthy

Canada
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
Alcon Research

Completed

Circadian Ocular Perfusion Pressure and Ocular Blood Flow

Glaucoma

United States
University of California, San Francisco
National Cancer Institute (NCI); Food and Drug Administration (FDA)

Completed

Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products

Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter

United States
Seoul National University Hospital

Withdrawn

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

Autoimmune Encephalopathy

Korea, Republic of
Kirstine Nyvold Bojsen-Moeller
University of Copenhagen

Unknown

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

Overweight | Bariatric Surgery (Gastric Bypass)

Denmark
Fondazione del Piemonte per l'Oncologia

Completed

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance (CHRONOS)

Colorectal Cancer

Italy
University of Patras

Completed

Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens

Postoperative Pain | Morbid Obesity | Postoperative Bowel Function | Postoperative Ambulation

Greece
Mansoura University

Completed

Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study

Minimal Hepatic Encephalopathy

Egypt
Mochida Pharmaceutical Company, Ltd.

Completed

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

Steatohepatitis

United States, Puerto Rico
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Healthy

Canada
Olivia Newton-John Cancer Research Institute
Austin Health; Roche Products Pty Limited; Ballarat Health Services

Active, not recruiting

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy (FLUORO)

Follicular Lymphoma

Australia
Aragon Institute of Health Sciences
Ministerio de Sanidad, Servicios Sociales e Igualdad

Unknown

Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock

Septic Shock | Severe Sepsis

Spain
Cubist Pharmaceuticals LLC

Completed

Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)

Proven or Suspected Gram-negative Bacterial Infection | Peri-operative Prophylaxis
First Affiliated Hospital Xi'an Jiaotong University

Completed

In-hospital Initiation of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction

Coronary Disease
National Cancer Institute (NCI)

Completed

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma

United States
University Hospital, Linkoeping

Unknown

The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow (Jonto01)

Cardiovascular Diseases | Vascular Diseases

Sweden
University Hospital Inselspital, Berne
Amgen; University of Bern

Completed

EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) (EVOPACS)

Acute Coronary Syndrome

Switzerland
Zuyderland Medisch Centrum
AtriCure, Inc.

Recruiting

Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (ICE)

Funnel Chest | Pectus Excavatum

Netherlands
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine

Migraine Prophylaxis

Bangladesh
Leonardo Clavijo
Amgen

Unknown

Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease (Evol-PAD)

Peripheral Arterial Disease

United States
National Research Council, Spain

Completed

Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome (OLNAMS)

Metabolic Syndrome

Spain
Radboud University Medical Center
Amgen

Recruiting

Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody (FITTER)

Coronary Artery Disease | Atherosclerosis of Coronary Artery

Netherlands
University Hospital, Grenoble

Recruiting

Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography (MICROPROTECT)

Atherosclerotic Cardiovascular Disease

France
Dubai Health Authority

Unknown

Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger

Trigger Finger

United Arab Emirates
University of Campinas, Brazil

Completed

EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial (EXCEED-BHS3)

Diabetes Mellitus, Type 2 | Dyslipidemia Associated With Type II Diabetes Mellitus | Hypertension Arterial

Brazil
Oyster Point Pharma, Inc.

Completed

Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy

Neurotrophic Keratopathy

United States
Institut Jantung Negara

Completed

Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting

Coronary Artery Disease | Neuromuscular Blockade | Coronary Artery Bypass Grafting | Postoperative Pulmonary Complication | Postoperative Pulmonary Atelectasis | Hypothermic Cardiopulmonary Bypass

Malaysia
University of Missouri-Columbia

Completed

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

Constipation Drug Induced

United States

Search clinical trials for: 12 mg/mL nicotine strength e-liquid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations